PHMMF vs BIIB: Which Stock is Better?

Side-by-side comparison of Pharma Mar SAU and Biogen Inc in 2026

Comparison Updated:

PHMMF

Pharma Mar SAU

$106.48

BIIB

Biogen Inc

$177.35

Key Metrics Comparison

MetricPHMMFBIIBWinner
Market Cap$1.68B$26.03BBIIB
P/E Ratio18.3420.04PHMMF
EPS (TTM)$5.07$8.85BIIB
Revenue Growth0.9%-0.1%PHMMF
Gross Margin94.5%78.9%PHMMF

Analyze PHMMF

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is PHMMF or BIIB a better investment?

Comparing PHMMF and BIIB: Pharma Mar SAU has a market cap of $1.68B while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between PHMMF and BIIB?

PHMMF (Pharma Mar SAU) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: PHMMF or BIIB?

Based on P/E ratios, PHMMF trades at a lower multiple (18.3x vs 20.0x).

Which is growing faster: PHMMF or BIIB?

PHMMF has higher revenue growth at 0.9% vs -0.1% for BIIB.

Which company is more profitable: PHMMF or BIIB?

Pharma Mar SAU (PHMMF) has higher gross margins at 94.5% compared to 78.9% for BIIB.

Which is the larger company: PHMMF or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $1.68B for PHMMF.

Should I buy PHMMF or BIIB in 2026?

Both PHMMF and BIIB have investment merit. PHMMF trades at $106.48 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between PHMMF and BIIB stock?

Key differences: Market Cap ($1.68B vs $26.03B), P/E Ratio (18.3x vs 20.0x), Revenue Growth (0.9% vs -0.1%), Gross Margin (94.5% vs 78.9%).

Popular Stock Comparisons